• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Brinzolamide
    3 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Azarga
    Novartis
    RX
    partial basket chart
    Multiple ingredients
    Azarga

    Carbonic Anhydrase Inhibitor, Nonselective β-Blocker. Brinzolamide 10 mg/ml, Timolol Maleate 5 mg/ml.
    BOTTLE: 5 ml. 1 dr ×2/d in conjunctival sac of the affected eye(s). See lit.
    Decrease of intra-ocular pressure (IOP) in adult pts. with open-ang. glauc. or ocular hypertens. for whom monother. provides insuffic. IOP reduct.
    C/I: Hypersens. Hypersens. to other β-block. Hypersens. to sulphonamides.
    Reactive airway dis. include. bronch. asthma/history of bronch. asthma, or severe COPD. Sinus bradycardia, sick sinus synd., sino-atrial block, 2nd/3rd degree AV block not control. with pace-maker. Overt CF, cardiogenic shock. Severe allergic rhinitis. Hyperchloraemic acidosis. Sev. renal impair.

    Azopt 1%
    Novartis
    RX
    partial basket chart
    Azopt 1%

    Carbonic Anhydrase Inhibitor. Brinzolamide 1%.
    OPHTH. DROPS (Suspension): 5 ml. 1
    drop into affect. eye(s) 2 - 3 x dly.
    Elevat. IOP in oc. hypertens., open angle
    glaucoma.
    C/I: Hypersens. to compos.,
    sulphonamides.

    Simbrinza
    Novartis
    RX
    partial basket chart
    Multiple ingredients
    Simbrinza

    Carbonic Anhydrase Inhibitor, α2 Agonist. Brinzolamide 10 mg/ml, Brimonidine Tartrate 2 mg/ml.
    BOTTLE: 5 ml. 1 dr×2/d in the affected eye(s). See lit.
    Decrease of elevated intraoc. pressure (IOP) in adult pts. with open-ang. glauc. or ocular hypertens. for whom monotherapy provides insuffic. IOP reduct.
    C/I: Hypersens. Hypersens. to sulphonamides. Pts. receiving MAO inhib.
    Pts on antidepressant. which affect noradrenergic transmission (e.g. TCA's & mianserin). Pts. with severe renal impair. Pts. with hyperchloraemic acidosis.
    Neonates & infants under the age of 2 yrs.

    CLOSE